Literature DB >> 9114054

Cytokine manipulation of primitive human hematopoietic cell self-renewal.

P W Zandstra1, E Conneally, A L Petzer, J M Piret, C J Eaves.   

Abstract

Previous studies have shown that primitive human hematopoietic cells detectable as long-term culture-initiating cells (LTC-ICs) and colony-forming cells (CFCs) can be amplified when CD34(+) CD38(-) marrow cells are cultured for 10 days in serum-free medium containing flt3 ligand (FL), Steel factor (SF), interleukin (IL)-3, IL-6, and granulocyte colony-stimulating factor. We now show that the generation of these two cell types in such cultures is differentially affected at the single cell level by changes in the concentrations of these cytokines. Thus, maximal expansion of LTC-ICs (60-fold) was obtained in the presence of 30 times more FL, SF, IL-3, IL-6, and granulocyte colony-stimulating factor than could concomitantly stimulate the near-maximal (280-fold) amplification of CFCs. Furthermore, the reduced ability of suboptimal cytokine concentrations to support the production of LTC-ICs could be ascribed to a differential response of the stimulated cells since this was not accompanied by a change in the number of input CD34(+) CD38(-) cells that proliferated. Reduced LTC-IC amplification in the absence of a significant effect on CFC generation also occurred when the concentrations of FL and SF were decreased but the concentration of IL-3 was high (as compared with cultures containing high levels of all three cytokines). To our knowledge, these findings provide the first evidence suggesting that extrinsically acting cytokines can alter the self-renewal behavior of primary human hematopoietic stem cells independent of effects on their viability or proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114054      PMCID: PMC20787          DOI: 10.1073/pnas.94.9.4698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy.

Authors:  S J Szilvassy; R K Humphries; P M Lansdorp; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 3.  Differentiation and proliferation of hematopoietic stem cells.

Authors:  M Ogawa
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

4.  Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor.

Authors:  D E Hogge; P M Lansdorp; D Reid; B Gerhard; C J Eaves
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

5.  Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.

Authors:  S Neben; D Donaldson; L Fitz; J Calvetti; T Neben; K Turner; F Hirayama; M Ogawa
Journal:  Exp Hematol       Date:  1996-06       Impact factor: 3.084

Review 6.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice.

Authors:  J A Nolta; M A Dao; S Wells; E M Smogorzewska; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

8.  Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow.

Authors:  P M Lansdorp; H J Sutherland; C J Eaves
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.

Authors:  A L Petzer; P W Zandstra; J M Piret; C J Eaves
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.

Authors:  P M Lansdorp; W Dragowska
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  35 in total

1.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Authors:  Kohshi Ohishi; Barbara Varnum-Finney; Irwin D Bernstein
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 3.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

Review 4.  Stem cell bioprocessing: fundamentals and principles.

Authors:  Mark R Placzek; I-Ming Chung; Hugo M Macedo; Siti Ismail; Teresa Mortera Blanco; Mayasari Lim; Jae Min Cha; Iliana Fauzi; Yunyi Kang; David C L Yeo; Chi Yip Joan Ma; Julia M Polak; Nicki Panoskaltsis; Athanasios Mantalaris
Journal:  J R Soc Interface       Date:  2009-03-06       Impact factor: 4.118

5.  Towards predictive models of stem cell fate.

Authors:  Sowmya Viswanathan; Peter W Zandstra
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

6.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

7.  Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.

Authors:  Tiki Bakhshi; Ryan C Zabriskie; Shamanique Bodie; Shannon Kidd; Susan Ramin; Laura A Paganessi; Stephanie A Gregory; Henry C Fung; Kent W Christopherson
Journal:  Transfusion       Date:  2008-09-16       Impact factor: 3.157

Review 8.  An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Authors:  Abhishek Kumar Singh; Mahendra Pratap Kashyap
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

9.  HIF1α-induced PDGFRβ signaling promotes developmental HSC production via IL-6 activation.

Authors:  Sung-Eun Lim; Virginie Esain; Wanda Kwan; Lindsay N Theodore; Mauricio Cortes; Isaura M Frost; Sarah Y Liu; Trista E North
Journal:  Exp Hematol       Date:  2016-10-15       Impact factor: 3.084

10.  Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model.

Authors:  Jaehyup Kim; Esmail D Zanjani; Christine M Jeanblanc; A Daisy Goodrich; Peiman Hematti
Journal:  Exp Hematol       Date:  2013-04-20       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.